APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Insulin Glargine

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Types
Single Dose Vial · Pre-filled Syringe
Applications
Treat Type2 Diabetes · Treat Type1 Diabetes

5 editions21 December 2025

View 5 research editions
$4,950Single user · USD · Market Analysis & ForecastExplore product: Insulin GlargineCompare research options for Insulin Glargine
APO Research, Inc.